Drugs / D635
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04156685 | Aug 2019 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
| Phase 1 | NCT03849339 | Jan → Feb 2019 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
| Phase 1 | NCT03849261 | Jan → Feb 2019 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D635 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03849339 ↗ |
| Route | Oral | “after oral administration of CKD-387 and D635 in healthy adults.” NCT03849261 ↗ |